NewEdge Advisors’s Horizon Therapeutics Public Limited Company Ordinary Shares HZNP Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q4 | – | Sell |
-800
| Closed | -$92.6K | – | 3946 |
|
|
2023
Q3 | $92.6K | Sell |
800
-454
| -36% | -$52.5K | ﹤0.01% | 1864 |
|
|
2023
Q2 | $129K | Buy |
1,254
+206
| +20% | +$21.2K | ﹤0.01% | 1773 |
|
|
2023
Q1 | $114K | Sell |
1,048
-446
| -30% | -$48.7K | ﹤0.01% | 1702 |
|
|
2022
Q4 | $56.3K | Sell |
1,494
-5,525
| -79% | -$208K | ﹤0.01% | 1671 |
|
|
2022
Q3 | $434K | Sell |
7,019
-910
| -11% | -$56.3K | 0.01% | 1037 |
|
|
2022
Q2 | $632K | Buy |
+7,929
| New | +$632K | 0.01% | 877 |
|
|
2022
Q1 | – | Sell |
-8,340
| Closed | -$899K | – | 1725 |
|
|
2021
Q4 | $899K | Sell |
8,340
-2,510
| -23% | -$271K | 0.01% | 787 |
|
|
2021
Q3 | $1.19M | Buy |
10,850
+425
| +4% | +$46.6K | 0.03% | 464 |
|
|
2021
Q2 | $976K | Buy |
10,425
+6,275
| +151% | +$587K | 0.03% | 501 |
|
|
2021
Q1 | $382K | Buy |
4,150
+29
| +0.7% | +$2.67K | 0.01% | 736 |
|
|
2020
Q4 | $301K | Buy |
4,121
+565
| +16% | +$41.3K | 0.01% | 761 |
|
|
2020
Q3 | $276K | Buy |
+3,556
| New | +$276K | 0.01% | 738 |
|
|
2020
Q1 | – | Sell |
-8,253
| Closed | -$298K | – | 929 |
|
|
2019
Q4 | $298K | Sell |
8,253
-377
| -4% | -$13.6K | 0.01% | 662 |
|
|
2019
Q3 | $235K | Sell |
8,630
-940
| -10% | -$25.6K | 0.01% | 703 |
|
|
2019
Q2 | $230K | Buy |
9,570
+109
| +1% | +$2.62K | 0.01% | 587 |
|
|
2019
Q1 | $250K | Buy |
+9,461
| New | +$250K | 0.02% | 572 |
|